CD4 and rheumatoid arthritis: SLAMF6 was increased in osteoarthritis and early RA ST (117), and in circulating early RA PD-1+CD4+ cells (54) and inhibition of SLAMF6 on CD4+PD-1+ peripheral cells from established RA patients decreased IgG production and plasmablast differentiation (53).